Sanara MedTech (SMTI) CEO reports share withholding to cover tax on vested stock

Rhea-AI Filing Summary

Sanara MedTech Inc. Chief Executive Officer Yon Seth D reported an automatic share withholding related to equity compensation. On the vesting of 13,466 shares of restricted stock, 3,852 shares of common stock were withheld by the company to satisfy tax withholding obligations, based on a value of $21.06 per share. No shares were issued or sold in this transaction, and following the withholding, the CEO directly holds 109,546 shares of common stock.

Insights

Insider transactions analyst

Routine tax withholding; no open-market trading by the CEO.

The disclosure shows shares of Sanara MedTech Inc. common stock were withheld to cover taxes on vested restricted stock. This is a standard, compensation-related mechanism rather than an open-market sale or purchase, and does not change the CEO’s cash exposure through trading.

The filing notes 3,852 shares withheld at $21.06 per share tied to vesting of 13,466 restricted shares, with no shares issued or sold. After this event, the CEO holds 109,546 shares directly, indicating the transaction is small relative to his position and appears routine.

Insider Trade Summary

Net Seller: 3,852 shares

Net Sell 1 txn

Insider Yon Seth D

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	3,852	$21.06	$81K

Holdings After Transaction: Common Stock — 109,546 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 13,466 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

Key Figures

Shares withheld for taxes: 3,852 shares Per-share tax value: $21.06 per share Restricted stock vested: 13,466 shares +1 more

4 metrics

Shares withheld for taxes 3,852 shares Common stock withheld to satisfy tax obligations

Per-share tax value $21.06 per share Value assigned to withheld shares on vesting date

Restricted stock vested 13,466 shares Annual vesting of previously granted restricted stock

Shares held after transaction 109,546 shares CEO’s direct common stock holdings after withholding

Key Terms

restricted stock, tax withholding obligations, Nasdaq Capital Market

3 terms

restricted stock financial

"annual vesting of 13,466 shares of restricted stock previously granted"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations in connection"

Nasdaq Capital Market financial

"price per share on the date on which the shares vested as reported on the Nasdaq Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/18/2026 - 04:02 PM Learn about SEC filing dates

FAQ

What insider transaction did Sanara MedTech (SMTI) report for CEO Yon Seth D?

Sanara MedTech reported that CEO Yon Seth D had 3,852 common shares withheld to cover tax obligations on vested restricted stock. This was a tax-withholding mechanism, not an open-market sale or purchase of SMTI shares.

Were any Sanara MedTech (SMTI) shares sold on the market in this Form 4?

No, the Form 4 states that no shares were issued or sold. Shares were withheld by Sanara MedTech to satisfy tax withholding obligations when 13,466 restricted shares vested for the CEO.

How many Sanara MedTech (SMTI) shares were withheld for taxes in this filing?

The filing shows 3,852 shares of Sanara MedTech common stock were withheld by the company. The withholding covered tax obligations arising from the annual vesting of 13,466 shares of previously granted restricted stock.

What price per share was used for the Sanara MedTech (SMTI) tax withholding?

The per-share value assigned to the withheld shares was $21.06. The filing notes this reflects the price per share on the vesting date as reported on the Nasdaq Capital Market for Sanara MedTech’s common stock.

How many Sanara MedTech (SMTI) shares does the CEO hold after this transaction?

After the tax-withholding transaction, CEO Yon Seth D directly holds 109,546 shares of Sanara MedTech common stock. This context shows the withheld amount is relatively small compared with his remaining direct position.

What triggered the Sanara MedTech (SMTI) Form 4 insider filing?

The Form 4 was triggered by the annual vesting of 13,466 restricted shares previously granted to the CEO. To satisfy tax withholding obligations from this vesting, 3,852 common shares were withheld by Sanara MedTech rather than sold on the market.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yon Seth D

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TEXAS 76102

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		F		3,852(1)	D	$21.06(1)	109,546	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 13,466 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

	/s/ Seth D. Yon	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)